Is skin perfusion pressure a useful screening tool for peripheral arterial disease in patients on hemodialysis?
Michael Davis and Sanjay Rajagopalan*
Correspondence *The Ohio State University School of Medicine, 473 West 12th Avenue, Dorothy M Davis Heart & Lung Research Institute, Columbus, OH 43210, USA
Email sanjay.rajagopalan@osumc.edu
This article has no abstract so we have provided the first paragraph of the full text.
PAD is common in patients on hemodialysis and portends a poor prognosis. Data from the Dialysis Outcomes and Practice Patterns Study—a prospective, international, observational study of patients on hemodialysis (n = 29,873)—have shown that PAD is associated with increased risks of all-cause mortality (hazard ratio [HR] 1.36; P <0.0001), cardiac mortality (HR 1.43; P <0.0001), and hospitalization for a major adverse cardiovascular event (HR 2.05; P <0.0001).1 Establishing the diagnosis of PAD might, therefore, identify a subset of patients on hemodialysis who have a very high cardiovascular risk, in this already at-risk patient population.
Full text of this article is available with one of the following:
- Membership of the International Society of Nephrology. If already a member, please login. If not please join the Society now
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please login for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or login above.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
